Clinical Trials
Spinal Cord Stimulation May Be A Boon For Stroke Patients
A small clinical trial has suggested that spinal cord stimulation may help stroke patients regain movement in their limbs and hands. In an article published in Nature Medicine, researchers detailed the experience of the first two people treated in...
Clinical Trials
HIV Simplified Treatment Options Effective In A Major Trial
As per the results of international research, which has the distinction of being the world’s first study into second-line human immunodeficiency virus- HIV therapy, 2 newer and simplified options in treatment are as effective as the standards of care...
Clinical Trials
Kidney Cancer Recurrence Can Be Gauged By DNA Mutations
One of the international studies on kidney cancer recurrence has found that physicians can forecast the likelihood of a disease returning by way of examining DNA mutations in the patients' tumours.
The study was undertaken by a team of 44...
Drug Research
South Australia Government Looks To Boost Biomanufacturing
Biomanufacturing industry is all set to get the much-needed push by the recent South Australian Government’s announcement when it comes to new initiatives as far as training and development of next generation researchers in this field are concerned.
This will...
Drug Research
Oligonucleotide Drugs To Witness Novel Sterilisation Process
There is a new report which has gone on to review the processing of the present state of sterile oligonucleotide drug product. This includes recommendations to help in the evaluation and development of the terminal sterilisation processes, as well...
Drug Research
Foetal Development Protein Can Aid Acute Leukaemia Aversion
A protein present in foetal development has been zeroed upon by the researchers that has a strong prophylactic effect versus acute myeloid leukaemia- AML.
Right during the foetal pregnancy stage, numerous vital cell programmes become active in the foetal development....
Drug Research
STAT5 To Play A Crucial Role In The Fight Against Cancer
STAT5 has long been regarded as an interesting target versus cancer, but after several decades of research, it was relegated to the undruggable category. Now, researchers at the University of Michigan Rogel Cancer Center have found success with a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read